Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP +-induced mitochondrial dysfunctions in neuronal cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 5, 2012, Pages 577-585

  Piao, Ying ^a   Kim, Hyo Geun ^b   Oh, Myung Sook ^b   Pak, Youngmi Kim ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Insulin signaling; Mitochondrial dysfunction; Mouse; MPP+; SH SY5Y

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2,3 DIHYDRO 1 METHYL 4 PHENYLPYRIDINIUM; BIOLOGICAL MARKER; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; CONTROLLED STUDY; CORPUS STRIATUM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENOMIC FRAGMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; METABOLIC SYNDROME X; MITOCHONDRIAL GENE; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TARGETING SIGNAL; MITOCHONDRIAL TOXICITY; MITOCHONDRIAL TRANSCRIPTION FACTOR A GENE; MYR AKT GENE; NERVE CELL CULTURE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEAR RESPIRATORY FACTOR 1 GENE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA; TRANSIENT TRANSFECTION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CORPUS STRIATUM; DNA-BINDING PROTEINS; FEMALE; HERBICIDES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEUROBLASTOMA; NEURONS; NF-E2-RELATED FACTOR 1; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TRANSCRIPTION FACTORS; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 84859422737     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2011.08.007     Document Type: Article

References (36)

1. M. D'Amelio, P. Ragonese, G. Sconzo, P. Aridon, and G. Savettieri Parkinson's disease and cancer: insights for pathogenesis from epidemiology Ann. N. Y. Acad. Sci. 1155 2009 324 334
2. J. Hardy, H. Cai, M.R. Cookson, K. Gwinn-Hardy, and A. Singleton Genetics of Parkinson's disease and parkinsonism Ann. Neurol. 60 2006 389 398 (Pubitemid 44684974)
3. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909 (Pubitemid 37130207)
4. M.G. Spillantini, M.L. Schmidt, V.M. Lee, J.Q. Trojanowski, R. Jakes, and M. Goedert Alpha-synuclein in Lewy bodies Nature 388 1997 839 840
5. C. Henchcliffe, and M.F. Beal Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis Nat. Clin. Pract. Neurol. 4 2008 600 609
6. D.J. Moore, A.B. West, V.L. Dawson, and T.M. Dawson Molecular pathophysiology of Parkinson's disease Annu. Rev. Neurosci. 28 2005 57 87 (Pubitemid 41098899)
7. C. Klein, and M.G. Schlossmacher The genetics of Parkinson disease: implications for neurological care Nat. Clin. Pract. Neurol. 2 2006 136 146
8. D.P. Narendra, S.M. Jin, A. Tanaka, D.F. Suen, C.A. Gautier, J. Shen, M.R. Cookson, and R.J. Youle PINK1 is selectively stabilized on impaired mitochondria to activate Parkin PLoS Biol. 8 2010 e1000298
9. I. Irrcher, H. Aleyasin, E.L. Seifert, S.J. Hewitt, S. Chhabra, M. Phillips, A.K. Lutz, M.W. Rousseaux, L. Bevilacqua, A. Jahani-Asl, S. Callaghan, J.G. MacLaurin, K.F. Winklhofer, P. Rizzu, P. Rippstein, R.H. Kim, C.X. Chen, E.A. Fon, R.S. Slack, M.E. Harper, H.M. McBride, T.W. Mak, and D.S. Park Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics Hum. Mol. Genet. 19 2010 3734 3746
10. P. Luoma, A. Melberg, J.O. Rinne, J.A. Kaukonen, N.N. Nupponen, R.M. Chalmers, A. Oldfors, I. Rautakorpi, L. Peltonen, K. Majamaa, H. Somer, and A. Suomalainen Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study Lancet 364 2004 875 882 (Pubitemid 39221065)
11. P.M. Keeney, J. Xie, R.A. Capaldi, and J.P. Bennett Jr. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled J. Neurosci. 26 2006 5256 5264 (Pubitemid 44315308)
12. P. Lestienne, J. Nelson, P. Riederer, K. Jellinger, and H. Reichmann Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect J. Neurochem. 55 1990 1810 1812
13. M.T. Hu, S.D. Taylor-Robinson, K.R. Chaudhuri, J.D. Bell, C. Labbe, V.J. Cunningham, M.J. Koepp, A. Hammers, R.G. Morris, N. Turjanski, and D.J. Brooks Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study Brain 123 Pt 2 2000 340 352 (Pubitemid 30055157)
14. T.B. Sherer, R. Betarbet, A.K. Stout, S. Lund, M. Baptista, A.V. Panov, M.R. Cookson, and J.T. Greenamyre An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage J. Neurosci. 22 2002 7006 7015 (Pubitemid 35379158)
15. R. Betarbet, T.B. Sherer, and J.T. Greenamyre Animal models of Parkinson's disease Bioessays 24 2002 308 318 (Pubitemid 34305686)
16. Y. Mizuno, N. Sone, and T. Saitoh Effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain J. Neurochem. 48 1987 1787 1793 (Pubitemid 17101550)
17. V.M. Mann, J.M. Cooper, D. Krige, S.E. Daniel, A.H. Schapira, and C.D. Marsden Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease Brain 115 Pt 2 1992 333 342
18. M.T. Lin, and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 2006 787 795 (Pubitemid 44622683)
19. R. Sandyk The relationship between diabetes mellitus and Parkinson's disease Int. J. Neurosci. 69 1993 125 130
20. J.K. Morris, H. Zhang, A.A. Gupte, G.L. Bomhoff, J.A. Stanford, and P.C. Geiger Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease Brain Res. 1240 2008 185 195
21. S.M. de la Monte Insulin resistance and Alzheimer's disease BMB Rep. 42 2009 475 481
22. S.Y. Ahn, Y.S. Choi, H.J. Koo, J.H. Jeong, W.H. Park, M. Kim, Y. Piao, and Y.K. Pak Mitochondrial dysfunction enhances the migration of vascular smooth muscles cells via suppression of Akt phosphorylation Biochim. Biophys. Acta 1800 2010 275 281
23. S. Lim, S.Y. Ahn, I.C. Song, M.H. Chung, H.C. Jang, K.S. Park, K.U. Lee, Y.K. Pak, and H.K. Lee Chronic exposure to the herbicide, atrazine, causes mitochondrial dysfunction and insulin resistance PLoS One 4 2009 e5186
24. D.R. Kaplan, K. Matsumoto, E. Lucarelli, and C.J. Thiele Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group Neuron 11 1993 321 331 (Pubitemid 23250349)
25. Y.S. Choi, S. Kim, H. Kyu Lee, K.U. Lee, and Y.K. Pak In vitro methylation of nuclear respiratory factor-1 binding site suppresses the promoter activity of mitochondrial transcription factor A Biochem. Biophys. Res. Commun. 314 2004 118 122 (Pubitemid 38058377)
26. Y.S. Choi, K.U. Lee, and Y.K. Pak Regulation of mitochondrial transcription factor A expression by high glucose Ann. N. Y. Acad. Sci. 1011 2004 69 77 (Pubitemid 38608393)
27. S.Y. Ahn, Y.S. Choi, H.J. Koo, J.H. Jeong, W.H. Park, M. Kim, Y. Piao, and Y.K. Pak Mitochondrial dysfunction enhances the migration of vascular smooth muscles cells via suppression of Akt phosphorylation Biochim. Biophys. Acta 1800 2009 275 281
28. C.Y. Han, and Y.K. Pak Oxidation-dependent effects of oxidized LDL: proliferation or cell death Exp. Mol. Med. 31 1999 165 173 (Pubitemid 30021332)
29. Y.S. Choi, J. Hoon Jeong, H.K. Min, H.J. Jung, D. Hwang, S.W. Lee, and Y. Kim Pak Shot-gun proteomic analysis of mitochondrial D-loop DNA binding proteins: identification of mitochondrial histones Mol. Biosyst. 7 2011 1523 1536
30. S.Y. Park, and W. Lee The depletion of cellular mitochondrial DNA causes insulin resistance through the alteration of insulin receptor substrate-1 in rat myocytes Diabetes Res. Clin. Pract. 77 Suppl. 1 2007 S165 S171
31. N. Matsuda, S. Sato, K. Shiba, K. Okatsu, K. Saisho, C.A. Gautier, Y.S. Sou, S. Saiki, S. Kawajiri, F. Sato, M. Kimura, M. Komatsu, N. Hattori, and K. Tanaka PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy J. Cell. Biol. 189 2010 211 221
32. J.V. Virbasius, and R.C. Scarpulla Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis Proc. Natl. Acad. Sci. U. S. A. 91 1994 1309 1313 (Pubitemid 24059000)
33. J.T. Dou, M. Chen, F. Dufour, D.L. Alkon, and W.Q. Zhao Insulin receptor signaling in long-term memory consolidation following spatial learning Learn. Mem. 12 2005 646 655 (Pubitemid 41770090)
34. G.S. Watson, and S. Craft The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment CNS Drugs 17 2003 27 45 (Pubitemid 36044347)
35. D.R. Alessi, S.R. James, C.P. Downes, A.B. Holmes, P.R. Gaffney, C.B. Reese, and P. Cohen Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha Curr. Biol. 7 1997 261 269 (Pubitemid 27176852)
36. Y.K. Pak, and J.H. Jeong Mitochondria: the secrete chamber of therapeutic targets for age-associated degenerative diseases Biomolecules Ther. 18 2010 235 245